Cargando…
USRCAT: real-time ultrafast shape recognition with pharmacophoric constraints
BACKGROUND: Ligand-based virtual screening using molecular shape is an important tool for researchers who wish to find novel chemical scaffolds in compound libraries. The Ultrafast Shape Recognition (USR) algorithm is capable of screening millions of compounds and is therefore suitable for usage in...
Autores principales: | , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
BioMed Central
2012
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505738/ https://www.ncbi.nlm.nih.gov/pubmed/23131020 http://dx.doi.org/10.1186/1758-2946-4-27 |
_version_ | 1782250802155356160 |
---|---|
author | Schreyer, Adrian M Blundell, Tom |
author_facet | Schreyer, Adrian M Blundell, Tom |
author_sort | Schreyer, Adrian M |
collection | PubMed |
description | BACKGROUND: Ligand-based virtual screening using molecular shape is an important tool for researchers who wish to find novel chemical scaffolds in compound libraries. The Ultrafast Shape Recognition (USR) algorithm is capable of screening millions of compounds and is therefore suitable for usage in a web service. The algorithm however is agnostic of atom types and cannot discriminate compounds with similar shape but distinct pharmacophoric features. To solve this problem, an extension of USR called USRCAT, has been developed that includes pharmacophoric information whilst retaining the performance benefits of the original method. RESULTS: The USRCAT extension is shown to outperform the traditional USR method in a retrospective virtual screening benchmark. Also, a relational database implementation is described that is capable of screening a million conformers in milliseconds and allows the inclusion of complex query parameters. CONCLUSIONS: USRCAT provides a solution to the lack of atom type information in the USR algorithm. Researchers, particularly those with only limited resources, who wish to use ligand-based virtual screening in order to discover new hits, will benefit the most. Online chemical databases that offer a shape-based similarity method might also find advantage in using USRCAT due to its accuracy and performance. The source code is freely available and can easily be modified to fit specific needs. |
format | Online Article Text |
id | pubmed-3505738 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2012 |
publisher | BioMed Central |
record_format | MEDLINE/PubMed |
spelling | pubmed-35057382012-11-30 USRCAT: real-time ultrafast shape recognition with pharmacophoric constraints Schreyer, Adrian M Blundell, Tom J Cheminform Methodology BACKGROUND: Ligand-based virtual screening using molecular shape is an important tool for researchers who wish to find novel chemical scaffolds in compound libraries. The Ultrafast Shape Recognition (USR) algorithm is capable of screening millions of compounds and is therefore suitable for usage in a web service. The algorithm however is agnostic of atom types and cannot discriminate compounds with similar shape but distinct pharmacophoric features. To solve this problem, an extension of USR called USRCAT, has been developed that includes pharmacophoric information whilst retaining the performance benefits of the original method. RESULTS: The USRCAT extension is shown to outperform the traditional USR method in a retrospective virtual screening benchmark. Also, a relational database implementation is described that is capable of screening a million conformers in milliseconds and allows the inclusion of complex query parameters. CONCLUSIONS: USRCAT provides a solution to the lack of atom type information in the USR algorithm. Researchers, particularly those with only limited resources, who wish to use ligand-based virtual screening in order to discover new hits, will benefit the most. Online chemical databases that offer a shape-based similarity method might also find advantage in using USRCAT due to its accuracy and performance. The source code is freely available and can easily be modified to fit specific needs. BioMed Central 2012-11-06 /pmc/articles/PMC3505738/ /pubmed/23131020 http://dx.doi.org/10.1186/1758-2946-4-27 Text en Copyright ©2012 Schreyer and Blundell; licensee Chemistry Central Ltd. http://creativecommons.org/licenses/by/2.0 This is an Open Access article distributed under the terms of the Creative Commons Attribution License ( http://creativecommons.org/licenses/by/2.0), which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited. |
spellingShingle | Methodology Schreyer, Adrian M Blundell, Tom USRCAT: real-time ultrafast shape recognition with pharmacophoric constraints |
title | USRCAT: real-time ultrafast shape recognition with pharmacophoric constraints |
title_full | USRCAT: real-time ultrafast shape recognition with pharmacophoric constraints |
title_fullStr | USRCAT: real-time ultrafast shape recognition with pharmacophoric constraints |
title_full_unstemmed | USRCAT: real-time ultrafast shape recognition with pharmacophoric constraints |
title_short | USRCAT: real-time ultrafast shape recognition with pharmacophoric constraints |
title_sort | usrcat: real-time ultrafast shape recognition with pharmacophoric constraints |
topic | Methodology |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC3505738/ https://www.ncbi.nlm.nih.gov/pubmed/23131020 http://dx.doi.org/10.1186/1758-2946-4-27 |
work_keys_str_mv | AT schreyeradrianm usrcatrealtimeultrafastshaperecognitionwithpharmacophoricconstraints AT blundelltom usrcatrealtimeultrafastshaperecognitionwithpharmacophoricconstraints |